Baxter International | BAX - 販売収入

株価
18.16
毎日の変更
-0.25 -1.36%
毎月
6.07%
毎年
-39.91%
Q2 予測
17.77




セールス 変化する 日付
Abbott USD 11.16B 300M 2026-03
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
Fresenius EUR 5.88B 400M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
ICU Medical USD 540.7M 3.7M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Laboratory Of America USD 3.52B 40M 2025-12
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12